Drawing based on the label description. No photo yet.
NVR TKI pill
Pill with imprint NVR TKI is yellow, capsule, 22 mm and has been identified as Nilotinib 200 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Novartis Pharmaceuticals Corporation.
Nilotinib 200 mg
- Imprint
- NVR TKI
- Strength
- 200 mg
- Used for
- Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
- Color
- Yellow
- Shape
- Capsule / oblong
- Size
- 22 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 0078-0526, 0078-0526-87, 0078-0526-51
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Nilotinib used for?
Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adult Patients With Newly Diagnosed Ph+ CML-CP
Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP
Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
From the FDA-approved label on DailyMed (published Sep 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows NVR TKI. The parts can be split between the two sides, so turn the pill over and check both.
- It is yellow, capsule, 22 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Tasigna.
Ingredients
Active: Nilotinib Hydrochloride Monohydrate
Inactive: Silicon Dioxide, Crospovidone, Lactose Monohydrate, Magnesium Stearate, Poloxamer 188, Gelatin, Ferric Oxide Red, Ferric Oxide Yellow, Titanium Dioxide
Other pills with imprint NVR TKI
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA19A
Lenalidomide 10 mg
Blue & yellow, capsule, 22 mm
Used for multiple myeloma and mantle-cell lymphoma
-
JSP 507
Butalbital, Aspirin, Caffeine and Codeine Phosphate 50 mg / 325 mg / 40 mg / 30 mg
Blue & yellow, capsule, 22 mm
Used for headache
Schedule III
-
R 8
Fenoprofen Calcium 300 mg
Orange & yellow, capsule, 23 mm
Used for pain and rheumatoid arthritis
-
K 16
Indomethacin 75 mg
White & yellow, capsule, 22 mm
Used for pain and rheumatoid arthritis
-
L82
Fenofibric Acid 135 mg
Blue & yellow, capsule, 22 mm
Used for high cholesterol and high triglycerides
-
AN 596
Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg
Red & yellow, capsule, 23 mm
Other Nilotinib pills
- RDY 150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN4 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- H 23 Nilotinib 150 mg Pink, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR BCR Nilotinib 150 mg Red, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N12 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 031150mg Nilotinib 150 mg Red, capsule, 20 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY Nilotinib Hydrochloride Monohydrate 150 mg Red, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia